01682nas a2200409   4500000000100000008004100001260004300042653002300085653002200108653003600130653001300166653001200179653001300191100001300204700001300217700001600230700001200246700001100258700001100269700001900280700001400299700001200313700001400325700001300339700001300352700001200365700001100377700001300388700001100401700001300412700001000425245008100435856011000516300001000626520061100636022002501247       2026                            d  c10/2026bOxford University Press (OUP)10aconjunctival swabs10adried blood spots10aPolymerase Chain Reaction (PCR)10aSerology10aSurveys10aTrachoma1 aTaylor E1 aDejene M1 aBakhtiari A1 aEpée E1 aGass K1 aGwyn S1 aHarding-Esch E1 aHokonya J1 aHsieh J1 aJimenez C1 aKebede F1 aMartin D1 aMwale C1 aNash S1 aOlobio N1 aOpon R1 aWatitu T1 aBah M00aLessons from a multi-country study into persistent and recrudescent trachoma  uhttps://academic.oup.com/inthealth/advance-article-pdf/doi/10.1093/inthealth/ihag101/72556868/ihag101.pdf  a1 - 53 a<p>This article summarizes the key lessons learned from a six-country study that collected data on complementary indicators related to Chlamydia trachomatis infection to better understand persistent and recrudescent trachoma. It highlights the practical challenges associated with adding these complementary indicators to routine trachoma surveys (often called ‘plus’ surveys) and suggests ways to address them. Although more complicated and costly to conduct, ‘plus’ surveys can improve data for programmatic decision-making and may enable some countries to reach elimination targets sooner.</p>
  a1876-3413, 1876-3405